KBL Merger (Unit)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch KBLMU and buy or sell other stocks, options, and ETFs commission-free!

About KBLMU

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. 

CEO
Jim N. Woody, MD, PhD
CEOJim N. Woody, MD, PhD
Employees
4
Employees4
Headquarters
Palo Alto, California
HeadquartersPalo Alto, California
Founded
2016
Founded2016
Employees
4
Employees4

KBLMU Key Statistics

Market cap
4.48M
Market cap4.48M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
348.40
Average volume348.40
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$14.52
52 Week high$14.52
52 Week low
$7.62
52 Week low$7.62
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.